Coronavirus | U.S. gives full approval to antiviral remdesivir to treat COVID-19
4 years, 2 months ago

Coronavirus | U.S. gives full approval to antiviral remdesivir to treat COVID-19

The Hindu  

The U.S. Food and Drug Administration on Thursday granted full approval to the antiviral drug remdesivir as a treatment for patients hospitalized with COVID-19, after conditional authorization was given in May. However, other treatments have received authorization for emergency use, though that approval can be revoked once the public health emergency sparked by the coronavirus pandemic is over. “The FDA is committed to expediting the development and availability of COVID-19 treatments during this unprecedented public health emergency,” said FDA Commissioner Stephen Hahn. “Today's approval is supported by data from multiple clinical trials that the agency has rigorously assessed and represents an important scientific milestone in the Covid-19 pandemic.” Europe and other countries such as Canada also have granted temporary approval for the use of remdesivir.

Coronavirus Drug Treat Approval Gilead Remdesivir  treatment  antiviral  patients  granted  drug  approval  emergency  coronavirus  covid19  gives  treat  remdesivir  recovery

History of this topic

FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans
1 year, 10 months ago

FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans

LA Times  

A two-shot dose of Evusheld at a University of Washington Medicine clinic in Seattle. For her patients, she said, “it was kind of like being told the seat belts in your car won’t work anymore, and we’re not going to be able to replace them with anything.” In recent months, nine new subvariants of the dominant Omicron strain have proven …

Remdesivir Could Reduce Covid Mortality if Given Early : Study
2 years, 1 month ago

Remdesivir Could Reduce Covid Mortality if Given Early : Study

News 18  

Remdesivir can reduce mortality in patients if administered within 9 days of COVID-19 symptom onset, according to a study conducted in Asian patients. Researchers from Tokyo Medical and Dental University have found that treatment with remdesivir within 9 days of COVID-19 symptom onset decreases mortality in Asian patients also taking corticosteroids, the study said. “In-hospital mortality rates were significantly lower …

Oral pill for COVID-19 approved by regulator
2 years, 4 months ago

Oral pill for COVID-19 approved by regulator

China Daily  

China Daily| Updated :2022-07-29 China's top drug regulator said on Monday that it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19 disease, adding to the growing medical arsenal against the novel coronavirus. Azvudine, developed by the Genuine Biotech Co based in Henan province, was first conditionally approved to treat HIV-1 infected adult patients …

WHO recommends Pfizer's pill Paxlovid for mild Covid cases
2 years, 8 months ago

WHO recommends Pfizer's pill Paxlovid for mild Covid cases

India Today  

The World Health Organisation has strongly recommended nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate Covid-19 patients at highest risk of hospital admission. Pfizer’s oral antiviral drug is strongly recommended for patients with non-severe Covid-19 who are at highest risk of developing severe disease and hospitalisation, such as unvaccinated, older, or immunosuppressed patients. The global health …

Health Matters: Dear Drug Regulator, Silence is Not Always Golden, Esp on WHO Pausing Covaxin Supply
2 years, 8 months ago

Health Matters: Dear Drug Regulator, Silence is Not Always Golden, Esp on WHO Pausing Covaxin Supply

News 18  

On April 2, the World Health Organization suspended the supply of Bharat Biotech’s Covaxin through the UN agencies after finding issues with the “good manufacturing practices”. For the past 15 days, not only health journalists, but even commoners who got Covaxin jabs are hoping to hear from the country’s drug regulatory agency – Central Drugs Standard Control Organization. Eventually, the …

Why Remdesivir’s Manufacturing Licence was Not Given to Pharma PSUs When People Were Battling Second Wave: Parl Panel
2 years, 9 months ago

Why Remdesivir’s Manufacturing Licence was Not Given to Pharma PSUs When People Were Battling Second Wave: Parl Panel

News 18  

Why none of the pharmaceutical public sector units were not granted a licence to produce Remdesivir when the common man was facing “hardships” in procuring the anti-Covid drug during the second wave, the parliamentary standing committee on chemicals and fertilizers has made an observation in its report. “However, the committee failed to understand that none of the Pharma Public Sector …

Health Matters: Don't Feel Guilty About Not Finding Remdesivir for Your Loved One. It Hardly Works
2 years, 11 months ago

Health Matters: Don't Feel Guilty About Not Finding Remdesivir for Your Loved One. It Hardly Works

News 18  

It was dinner time when she called for help. They don’t want to use it, but keep it.” Much before the outbreak of second wave, in November 2020, the World Health Organization issued a conditional recommendation against the use of Remdesivir in hospitalised patients, regardless of disease severity saying “there is currently no evidence that Remdesivir improves survival and other …

New COVID-19 treatment rules: India cuts down use of Remdesivir, Tocilizumab, multivitamins, steroids
2 years, 11 months ago

New COVID-19 treatment rules: India cuts down use of Remdesivir, Tocilizumab, multivitamins, steroids

Firstpost  

According to the new guidelines, Remdesivir may be considered only in patients who have completed 10 days since the start of the symptoms and require supplemental oxygen. While it states that doctors can “consider Remdesivir for five days to treat hospitalised patients with COVID-19”, it also mentions that “no evidence of benefit for treatment more than five days”. Discouraging the …

India Cuts Use of Remdesivir, Tocilizumab, Multivitamins, Steroids in Covid-19 Treatment
2 years, 11 months ago

India Cuts Use of Remdesivir, Tocilizumab, Multivitamins, Steroids in Covid-19 Treatment

News 18  

India has cut down on the use of the experimental drug Remdesivir and immunosuppressive drug Tocilizumab for the treatment of Covid-19. While it states that doctors can “consider Remdesivir for five days to treat hospitalised patients with Covid-19”, it also mentions that “no evidence of benefit for treatment more than five days”. Discouraging the overuse of steroids, the protocol for …

A shot in the arm: The Hindu Editorial on new modes of COVID-19 treatment
3 years ago

A shot in the arm: The Hindu Editorial on new modes of COVID-19 treatment

The Hindu  

If full vaccination using any COVID-19 vaccine greatly reduces a person’s risk of progressing to severe disease and death, then the move by the U.S. FDA to grant emergency-use authorisation to two oral antiviral drugs for certain categories of people who are likely to become severely ill provides a much-needed fillip to fight the disease. Unlike in the case of …

Pfizer Covid-19 antiviral pill: Biden says he’s ‘encouraged by the promising data’
3 years ago

Pfizer Covid-19 antiviral pill: Biden says he’s ‘encouraged by the promising data’

CNN  

Washington CNN — President Joe Biden on Tuesday praised Pfizer’s report that its experimental treatment for Covid-19 cut the risk of hospitalization or death by 89% if given to high-risk adults within a few days of their first symptoms. “I am encouraged by the promising data released by Pfizer today, showing that its antiviral pill is effective at reducing the …

Merck asks EU drug regulator to authorise its Covid-19 pill
3 years, 1 month ago

Merck asks EU drug regulator to authorise its Covid-19 pill

Hindustan Times  

The European Medicines Agency said it has received a request from Merck to authorise its coronavirus antiviral, the first pill shown to treat Covid-19. In a statement Tuesday, the EU drug regulator said it had started evaluating molnupiravir, made by Merck and Ridgeback Biotherapeutics, and that a decision could be made within weeks on whether it might be cleared. Last …

EU regulator recommends Merck’s COVID-19 pill for emergency use
3 years, 1 month ago

EU regulator recommends Merck’s COVID-19 pill for emergency use

Al Jazeera  

The European Union’s medicines watchdog has advised its member states they can use a potentially groundbreaking COVID-19 antiviral pill in emergency situations triggered by soaring infection rates, ahead of the treatment’s formal approval across the bloc. Molnupiravir, which is produced by Merck and Ridgeback Biotherapeutics, can be given within five days of first symptoms to treat adults who do not …

Pfizer says COVID-19 pill cut hospital, death risk by 90%
3 years, 1 month ago

Pfizer says COVID-19 pill cut hospital, death risk by 90%

Associated Press  

WASHINGTON — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus. Competitor Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on …

Molnupiravir: UK authorizes Merck/Ridgeback Biotherapeutics’ antiviral to treat mild-to-moderate Covid-19
3 years, 1 month ago

Molnupiravir: UK authorizes Merck/Ridgeback Biotherapeutics’ antiviral to treat mild-to-moderate Covid-19

CNN  

CNN — The UK Medicines and Healthcare Products Regulatory Agency said Thursday it had authorized Merck and Ridgeback Biotherapeutics’ oral antiviral, molnupiravir, to treat mild-to-moderate Covid-19 in adults at risk for severe illness. The companies have sought US Food and Drug Administration emergency use authorization for the drug, and the FDA said it will convene its Antimicrobial Drugs Advisory Committee …

UK approves Merck’s antiviral COVID-19 pill in world first move
3 years, 1 month ago

UK approves Merck’s antiviral COVID-19 pill in world first move

Al Jazeera  

Merck’s molnupiravir to be given to recently-infected COVID-19 patients twice a day, for five days. The United Kingdom has become the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by Merck and Ridgeback Biotherapeutics. Merck’s molnupiravir has been closely watched since data last month showed it could halve the chances of dying or …

Merck seeks first US authorization for Covid-19 tablet
3 years, 2 months ago

Merck seeks first US authorization for Covid-19 tablet

Live Mint  

Merck & Co Inc said on Monday it has applied for US emergency use authorization for its tablet to treat mild-to-moderate patients of COVID-19, putting it on course to become the first oral antiviral medication for the disease. An authorization from the US Food and Drug Administration could help change clinical management of COVID-19 as the pill can be taken …

Merck seeks FDA emergency use authorization for experimental antiviral Covid-19 treatment molnupiravir
3 years, 2 months ago

Merck seeks FDA emergency use authorization for experimental antiviral Covid-19 treatment molnupiravir

CNN  

CNN — Merck said Monday it is seeking US Food and Drug Administration emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir. “At the interim analysis, molnupiravir reduced the risk of hospitalization or death by approximately 50%; 7.3% of patients who received molnupiravir were either hospitalized or died through Day 29 following randomization, compared with 14.1% of placebo-treated patients,” …

Merck seeks US authorisation for pill to treat COVID
3 years, 2 months ago

Merck seeks US authorisation for pill to treat COVID

Al Jazeera  

US pharmaceutical giant submits request for FDA approval for molnupiravir pill to treat mild-to-moderate COVID-19 cases. US pharmaceutical company Merck has requested emergency authorisation for its experimental pill to treat mild-to-moderate cases of COVID-19, in what would add a promising, new tool to the global fight against the virus. Merck submitted the application for molnupiravir, which it said earlier this …

New coronavirus anti-viral med is “welcome, but not a miracle cure”: Virologist
3 years, 2 months ago

New coronavirus anti-viral med is “welcome, but not a miracle cure”: Virologist

NL Times  

Pharmaceutical company Merck announced last week that its antiviral medicine Molnupiravir could prevent 50 percent of coronavirus-related hospital admissions and deaths in high-risk groups if administered in time. According to virologists, this new treatment is a "welcome addition," but not a "miracle cure," they said to NOS. According to him, especially oral administration is "a welcome addition" to the treatment …

Merck Covid pill: What would an antiviral pill mean for the fight against Covid-19?
3 years, 2 months ago

Merck Covid pill: What would an antiviral pill mean for the fight against Covid-19?

CNN  

CNN — Merck and Ridgeback Biotherapeutics announced on Friday early result that indicate their experimental oral antiviral drug molnupiravir might halve the risk of death or hospitalization from Covid-19. But Merck says it will seek authorization from the US Food and Drug Administration, and if it’s granted, the drug could be the first antiviral treatment available orally to fight Covid-19. …

WHO Tests 3 Drugs for Treating Coronavirus Infection
3 years, 4 months ago

WHO Tests 3 Drugs for Treating Coronavirus Infection

News 18  

The World Health Organization says it will soon test three drugs used for other diseases to see if they might help patients sickened by the coronavirus. In a statement on Wednesday, the U.N. health agency says the three drugs would be adopted into the next phase of its ongoing global research into identifying potential treatments for COVID-19. The drugs were …

Remdesivir, HCQ have no antiviral effects: WHO study
3 years, 5 months ago

Remdesivir, HCQ have no antiviral effects: WHO study

India TV News  

Neither Remdesivir, nor hydroxychloroquine helps in recovery of patients hospitalised due to Covid-19, according to a new study conducted by the World Health Organization. The study, led by researchers from the Oslo University Hospital in Norway, found that lack of antiviral effect with Remdesivir and HCQ remained consistent despite patient age, symptom duration, degree of viral load, and presence of …

US to spend $3.2B on treatments for COVID-19, other viruses
3 years, 6 months ago

US to spend $3.2B on treatments for COVID-19, other viruses

Associated Press  

WASHINGTON — The United States is devoting $3.2 billion to speed development of antiviral pills to treat COVID-19 and other dangerous viruses that could turn into pandemics. The new program will invest in “accelerating things that are already in progress” for COVID-19 but also would work to come up with treatments for other viruses, said Dr. Anthony Fauci, the nation’s …

Biden administration will spend $3.2 billion on development of antiviral pills for treating COVID-19
3 years, 6 months ago

Biden administration will spend $3.2 billion on development of antiviral pills for treating COVID-19

Daily Mail  

The Biden administration is devoting $3.2 billion to help develop antiviral pills to treat COVID-19, officials said on Thursday. The U.S. government has committed $3.2 billion to help develop antiviral pills to treat COVID-19, officials including Dr Anthony Fauci announced on Thursday Several pills are in development that will be used to minimize symptoms of the virus early on in …

Doctors welcome India’s COVID treatment protocol for children
3 years, 6 months ago

Doctors welcome India’s COVID treatment protocol for children

The Hindu  

Doctors while welcoming the latest Union Health Ministry’s treatment guidelines for COVID management in children, underlined the need to “create awareness to prevent misinterpretation which could prove counterproductive.” The Directorate General of Health Services in its comprehensive guidelines for the management of COVID-19 among children has said that Remdesivir is not recommended in this population. Rahul Nagpal, director- Pediatrics and …

Don't Use Remdesivir, Limit CT Scan, Steroid: Centre's Covid Treatment Guidelines for Kids
3 years, 6 months ago

Don't Use Remdesivir, Limit CT Scan, Steroid: Centre's Covid Treatment Guidelines for Kids

News 18  

The Centre late on Wednesday night released a list of guidelines to manage Covid-19 among children as anxiety over the third wave continues. AIIMS director Dr Randeep Guleria said that 60-70 percent of the children, who got infected and were hospitalised during the second wave, had either co-morbidities or low immunity, and healthy children recovered with mild illness without need …

DGHS issues COVID-19 treatment guidelines: Here is what document recommends on Remdesivir, Tocilizumab
3 years, 6 months ago

DGHS issues COVID-19 treatment guidelines: Here is what document recommends on Remdesivir, Tocilizumab

Firstpost  

Among the drugs and treatment methods that have been removed from the recommendations are Ivermectin, Azithromycin and plasma therapy The Union health ministry has issued guidelines on management of COVID-19 patients, dropping many drugs which have been widely used for treatment until now. While Remdesivir has been granted Emergency Use Authorisation, Tocilizumab has been approved for off-label use only FOLLOW …

Govt Issues Advisory for Rational Use of Remdesivir in Covid-19 Treatment
3 years, 6 months ago

Govt Issues Advisory for Rational Use of Remdesivir in Covid-19 Treatment

News 18  

The government on Monday issued an advisory for rational use of Remdesivir in COVID-19 treatment, underlining that the anti-viral drug must be advised by senior faculty members directly involved in the patient's care. To stop the misuse of Remdesivir, the government further recommended that if the drug is to be advised or ordered during odd hours, it should be done …

Exercise extreme caution in Remdesivir use: Centre
3 years, 6 months ago

Exercise extreme caution in Remdesivir use: Centre

The Hindu  

The Health Ministry said on Monday that Remdesivir, a drug currently used in treatment of COVID-19, can be used only in select moderate/ severe hospitalised patients on supplemental oxygen, as it is a reserve drug approved under the Emergency Use Authorization based on limited scientific evidence globally. In a revised advisory, it said the drug is not indicated in patients …

DGHS drops Ivermectin, Doxycycline from Covid-19 treatment; ICMR rules unchanged
3 years, 6 months ago

DGHS drops Ivermectin, Doxycycline from Covid-19 treatment; ICMR rules unchanged

India Today  

The Union Health Ministry and Family Welfare's directorate general of health services has issued revised guidelines to stop the use of Ivermectin and Doxycycline in Covid-19 treatment. Meanwhile, about Remdesivir, the DGHS guidelines said, "Remdesivir is a reserved drug approved by DCG under Emergency Use Authorization only based on limited scientific evidence globally. At a time when India is seeing …

No evidence of Remdesivir's effectiveness, might be dropped as COVID-19 treatment: Dr DS Rana
3 years, 7 months ago

No evidence of Remdesivir's effectiveness, might be dropped as COVID-19 treatment: Dr DS Rana

Firstpost  

Ganga Ram hospital Chairperson Dr DS Rana said, “Medicines that do not have any activity to work, will have to be discontinued.” Ganga Ram hospital Chairperson Dr DS Rana on Tuesday said that Remdesivir is also being considered to be dropped from COVID-19 treatment soon as there is no evidence of its effectiveness in treating COVID-19 patients. While talking to …

Remdesivir Sale To Be Shifted To Chennai Nehru Indoor Stadium
3 years, 7 months ago

Remdesivir Sale To Be Shifted To Chennai Nehru Indoor Stadium

The Quint  

Chief Minister MK Stalin recently announced that the government will open Remdesivir counters at Madurai, Coimbatore, Trichy and Tirunelveli to address the state-wide shortage of the anti viral drug. In its submissions to the Madras HC, the state government added that it had received 250,000 vials of Remdesivir so far and the minimum requirement in the state was 20,000 vials …

Coronavirus Fact Check: Is Remdesivir life saving drug in COVID19, can it be given to patients at home?
3 years, 7 months ago

Coronavirus Fact Check: Is Remdesivir life saving drug in COVID19, can it be given to patients at home?

India TV News  

During COVID 19 second wave in India, a number of people are seen hunting for oxygen cylinders, ICU beds and many more medical facilities across the country. Know all about it here: According to an infographic video shared by PIB fact check, a verified Twitter account by the government of India to counter misinformation on govt. Meanwhile, India recorded 362,727 …

When to use Remdesivir, Ivermectin? India's Covid treatment protocol and what experts say
3 years, 7 months ago

When to use Remdesivir, Ivermectin? India's Covid treatment protocol and what experts say

India Today  

As the second wave of Covid-19 wreaks havoc across the country, the spotlight is on what India has recommended and what it hasn't for the management of adult patients. A look at India’s clinical management protocol: Covid treatment protocol for people with mild disease In the case of mild infection, upper respiratory tract symptoms like fever without shortness of breath …

Zydus Cadila Prices Covid-19 Medicine 'Virafin' at Rs 11,995 Per Dose
3 years, 7 months ago

Zydus Cadila Prices Covid-19 Medicine 'Virafin' at Rs 11,995 Per Dose

News 18  

Days after receiving approval for emergency use of its medicine ‘Virafin’ to treat moderate cases of COVID-19, Zydus Cadila has reportedly pegged the price of the drug at Rs 11,995 per dose. Zydus Cadila has claimed outlined this medicine, technically referred to as Pegylated Interferon alpha-2b, can be given when there is a moderate degree of infection. During the phase …

Families of Covid patients struggle to get Remdesivir in Tamil Nadu amid shortage
3 years, 7 months ago

Families of Covid patients struggle to get Remdesivir in Tamil Nadu amid shortage

India Today  

Instances of non-availability, hoarding and illegal sale of drugs used in the treatment of Covid-19 are surfacing from parts of Tamil Nadu. Speaking to India Today TV, Ibris, whose brother is infected with Covid-19 and undergoing treatment at a private hospital, said, "Remdesivir costs Rs 25,000 in the hospital where my brother is being treated." Tamil Nadu Chief Minister MK …

What Widespread Recommendation of Remdesivir for COVID-19 and Its Shortage Teach Us
3 years, 7 months ago

What Widespread Recommendation of Remdesivir for COVID-19 and Its Shortage Teach Us

News 18  

Soon after the start of the second wave of COVID-19 pandemic in India, the images of people standing in long queues outside the chemist stores/pharmacies across India, were all over the newspapers. Though clinical trials have not found Remdesivir beneficial in COVID-19 treatment; however, clinicians in India and even the national COVID-19 task force and expert groups in India continue …

COVID-19 Treatment: Cipla to manufacture and sell Eli Lilly's baricitinib in India
3 years, 7 months ago

COVID-19 Treatment: Cipla to manufacture and sell Eli Lilly's baricitinib in India

News 18  

Cipla on Monday announced that it has signed an agreement with Eli Lilly and Company to manufacture baricitinib for COVID-19 treatment. Baricitinib earlier received restricted emergency use approval by y the Central Drugs Standard Control Organization for use in combination with remdesivir for the treatment of hospitalized COVID-19 adult patients requiring supplemental oxygen, Cipla said. “We hope that our donations …

Covid-19: Remdesivir Allocation Made Up to May 16 to Ensure Availability, Says Union Minister
3 years, 7 months ago

Covid-19: Remdesivir Allocation Made Up to May 16 to Ensure Availability, Says Union Minister

News 18  

To ensure smooth supply of remdesivir used in the treatment of COVID-19 across the country, the allocation of the antiviral drug to the states and union territories has been made up to May 16, Union Chemicals and Fertilisers Minister Sadananda Gowda said on Friday. This will ensure smooth supply of Remdesivir across country so that no patient face difficulty in …

Health Ministry's advisory for Covid patients in home isolation, their caregivers | All you need to know
3 years, 7 months ago

Health Ministry's advisory for Covid patients in home isolation, their caregivers | All you need to know

India Today  

Decision to administer antiviral drug Remdesivir to a Covid patient must be taken by a medical professional, said Dr Randeep Guleria. Addressing a press conference on Friday, the Director of AIIMS-New Delhi also rolled out an advisory for patients in home isolation with mild/asymptomatic infection. Health Ministry's advisory for Covid patients/caregivers in home isolation: Those who have tested positive for …

Pfizer may have an anti-viral COVID-19 pill available by the end of the year
3 years, 7 months ago

Pfizer may have an anti-viral COVID-19 pill available by the end of the year

Salon  

Pfizer, which along with Moderna developed successful mRNA vaccines against COVID-19 late last year, announced on Tuesday that it could have ready by the end of the year an experimental oral drug which would treat COVID-19 as soon as patients display symptoms. Gandhi said that it was a "promising" oral antiviral drug, one that "could be used easily in the …

Doctors divided over use but scramble for Remdesivir continues
3 years, 7 months ago

Doctors divided over use but scramble for Remdesivir continues

The Hindu  

The scramble for Remdesivir, the anti-viral drug used in COVID-19 management, is increasing by the day even as doctors are divided on its use. Private Hospitals and Nursing Homes Association president H.M. Prasanna said that the helpline set up by the government is of little use. Manjunath, nodal officer for labs and testing in the State’s COVID-19 task force, said …

American biopharmaceutical company Gilead announces steps to expand Remdesivir availability in India
3 years, 7 months ago

American biopharmaceutical company Gilead announces steps to expand Remdesivir availability in India

India TV News  

American biopharmaceutical company Gilead has announced steps to expand the availability of remdesivir, a key therapeutic medicine used in the treatment of COVID-19 patients, in India. "The recent surge of COVID-19 cases in India is having a devastating impact on communities and has created unprecedented pressure on health systems," Johanna Mercier, the chief commercial officer of Gilead Sciences said on …

Russian firm awaits government approval to ship remdesivir to India
3 years, 7 months ago

Russian firm awaits government approval to ship remdesivir to India

India Today  

Russian pharmaceutical firm Pharmasyntez said on Monday it was ready to ship up to 1 million packs of the remdesivir antiviral drug to India by end-May to help fight a surge in Covid-19 cases there, once it has received the approval of Russia's government. The move comes soon after the drug's patent holder, US firm Gilead Sciences, filed a lawsuit …

Coronavirus | Counter set up at KMC to sell Remdesivir
3 years, 7 months ago

Coronavirus | Counter set up at KMC to sell Remdesivir

The Hindu  

The Government Kilpauk Medical College Hospital has launched a separate counter to sell Remdesivir, an injection administered to patients undergoing treatment for COVID-19 infection in hospitals. Some people had taken to social media complaining that the drug, used to treat patients on oxygen support, was being sold for as much as ₹20,000. To purchase, the patient’s family must produce a …

COVID is a 'mild disease', less than 5% of patients need ventilator, says AIIMS chief Randeep Guleria
3 years, 8 months ago

COVID is a 'mild disease', less than 5% of patients need ventilator, says AIIMS chief Randeep Guleria

Firstpost  

Coronavirus is mostly a “mild disease” and there is no need to panic, AIIMS director Dr Randeep Guleria said at a press conference in Delhi on Sunday. The AIIMS director, appealing to the public not to hoard Remdesevir or oxygen cylinders at home, said 85 to 90 percent of people get only mild coronavirus infections. “About 85 to 90 percent …

Centre to Ramp UP Remdesivir Production From 38.80 Lakh Units Per Month to 74 Lakh Units Per Month From May: MHA
3 years, 8 months ago

Centre to Ramp UP Remdesivir Production From 38.80 Lakh Units Per Month to 74 Lakh Units Per Month From May: MHA

News 18  

The production of life-saving Remdesivir injection used for the treatment of Covid-19 patients and is currently in scarcity in the country, will be augmented to 74 lakh units by next month from 38.80 lakh units now, the Union home ministry said. Several steps have been taken to augment the production capacity of the seven licensed manufacturers of Remdesivir injection in …

Centre issues updated clinical guidance for management of COVID-19 patients
3 years, 8 months ago

Centre issues updated clinical guidance for management of COVID-19 patients

The Hindu  

The Union Health Ministry has issued an updated ‘Clinical Guidance for Management of Adult COVID-19 Patients’ recommending emergency use authorisation of remdesivir for patients with moderate to severe diseases, requiring supplemental oxygen, within 10 days of onset of symptoms. The guidelines issued by AIIMS, ICMR-COVID-19 National Task Force and the Joint Monitoring Group under the ministry stated that tocilizumab may …

'Not a Life-Saving Drug': ICMR Suggests Safe Use of Remdesivir in Covid-19
3 years, 8 months ago

'Not a Life-Saving Drug': ICMR Suggests Safe Use of Remdesivir in Covid-19

News 18  

The Indian Council of Medical Research on Tuesday shared some suggestions for rational and safe use of Remdesivir in Covid-19 as the demand for the medicine has increased for treating coronavirus patients especially in Covid-hit states including Maharashtra, Delhi, Karnataka and others. Remdesivir is one of the investigational drugs approved for emergency use in treating hospitalized Covid-19 patients. Suggestion for …

Discover Related